Harvard Bioscience HBIO
NASDAQ HBIO
$7.48 -0.07 (-0.93%)
At close: Aug 21, 2026 · 4:00 PM EDT

Harvard Bioscience (HBIO) Income from Discontinued Operations (2017 - 2018)

Harvard Bioscience (HBIO) posted quarterly Income from Discontinued Operations of 442000.0 for Q4 2018, up 162.52% year-over-year from 168369.61 in Q4 2017, and up 4520.0% quarter-over-quarter from 10000.0 in Q2 2018.

Harvard Bioscience (HBIO) Income from Discontinued Operations (2017 - 2018) Analysis & Trends

Harvard Bioscience (HBIO) has reported Income from Discontinued Operations for 2 consecutive years, with 442000.0 the latest figure, recorded in Q4 2018.

  • In Q4 2018, Income from Discontinued Operations rose 162.52% year-over-year to 442000.0; the TTM figure through Sep 2019 stood at 442000.0 (up 127.8% YoY), while the FY2018 annual figure was 441000.0, up 28.53% from the prior year.
  • Income from Discontinued Operations rose to 442000.0 in Q4 2018 per HBIO's latest filing, from 10000.0 in the prior quarter.
  • Across five years, Income from Discontinued Operations topped out at 442000.0 in Q4 2018 and bottomed at 873000.0 in Q1 2018.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -74.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -9.00 Mn
10 Harvard Bioscience 33.45 Mn 26.94 Mn 12.63 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 442,000.00
Jun 30, 2018 -10,000.00
Mar 31, 2018 -873,000.00
Dec 31, 2017 -707,000.00
Sep 30, 2017 26,000.00
Jun 30, 2017 34,000.00
Mar 31, 2017 30,000.00